# Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19

> **NCT04535700** · PHASE4 · COMPLETED · sponsor: **Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal** · enrollment: 8 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Pioglitazone 30 mg
- **OTHER:** standard of care

## Key facts

- **NCT ID:** NCT04535700
- **Lead sponsor:** Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-18
- **Primary completion:** 2021-11-19
- **Final completion:** 2022-01-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04535700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04535700, "Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04535700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*